News Archive

30 Mar 2023

RoslinCT granted commercial manufacturing license

14 Sep 2022

Lykan Bioscience and RoslinCT announce Scientific Advisory Board

05 Sep 2022

ESGCT 29th Congress, in collaboration with BSGCT: 11 to 14th October 2022

UK Advanced Therapies Network: Monday 10th October 2022, 3pm to 6pm

04 Aug 2022

RoslinCT and Lykan Bioscience combine to create leading Advanced Cell Therapy CDMO

25 May 2022

RoslinCT announces appointment of Peter Coleman as CEO

11 Jan 2022

GHO Capital invests in RoslinCT, a leading cell therapy CDMO

27 Oct 2021

Delivering a world class cell and gene therapy facility

11 Oct 2021

RoslinCT opens new state-of-the-art cell and gene therapy manufacturing facility

29 Jun 2021

Cell and Gene Therapy Catapult to expand to Edinburgh BioQuarter